1 – 14 of 14
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
S100A6 is a critical regulator of hematopoietic stem cells.
2020) In Leukemia(
- Contribution to journal › Article
- 2018
-
Mark
A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1
(
- Contribution to journal › Article
- 2015
-
Mark
TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Disruption of the 5S RNP-Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia.
(
- Contribution to journal › Article
- 2012
-
Mark
SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q- myelodysplastic syndrome.
(
- Contribution to journal › Article
- 2011
-
Mark
Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications
(
- Contribution to journal › Scientific review
-
Mark
The role of Smad signaling in hematopoiesis and translational hematology.
(
- Contribution to journal › Article
-
Mark
High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event.
(
- Contribution to journal › Article
- 2010
-
Mark
PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression
(
- Contribution to journal › Article
- 2005
-
Mark
The role of Smad signaling in hematopoiesis.
(
- Contribution to journal › Scientific review
-
Mark
Gene expression profiling demonstrates that TGF-{beta}1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-{beta} signaling.
(
- Contribution to journal › Article
- 2003
-
Mark
Reduced proliferative capacity of hematopoietic stem cells deficient in hoxb3 and hoxb4.
(
- Contribution to journal › Article
- 2002
-
Mark
Development of gene therapy for hematopoietic stem cells using lentiviral vectors.
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium
(
- Contribution to journal › Article